Metformin inhibits 2, 7, dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P450 1A1/Aryl hydrocarbon receptor signaling pathway (Toxicology and Applied Pharmacology

Journal Article